Skip to content

A randomized controlled single-center clinical trial of perioperative rehabilitation to promote recovery of urinary continence after holmium laser enucleation of the prostate

A randomized controlled single-center clinical trial of perioperative rehabilitation to promote recovery of urinary continence after holmium laser enucleation of the prostate

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085870
Enrollment
Unknown
Registered
2024-06-20
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary incontinence after prostate enucleation

Interventions

Experimental group:Perioperative pelvic floor muscle group rehabilitation exercises
Control Group:Levator ani exercises afer sugery

Sponsors

Shanghai Fourth People's Hospital, Affiliated to Tongji University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Male = age 50 years old; (2) Prostatic hyperplasia, recurrent hematuria, recurrent urinary tract infection, recent acute urinary retention, bladder stones, renal impairment or poor drug treatment effect, willing to undergo Holep surgery; (3) Agree to complete the urination diary (optional), urine pad test and other examination items during the test; (4) Serum prostate-specific antigen (PSA) 4ng/mL, but prostate puncture confirms benign prostate tissue. (5) Prostate ultrasound showed that the patient's prostate volume (PV) was = 30cm3. (6) Have not received acupuncture, bioelectric feedback and other treatments within 1 week before the introduction period; (7) Understand the risks and benefits of participating in the study, voluntarily take the test, and be able to sign the informed consent form;

Exclusion criteria

Exclusion criteria: (1) Patients with Alzheimer's disease, cerebral infarction, or cognitive dysfunction caused by drugs or alcohol; (2) Bladder dysfunction caused by previous diseases such as spina bifida, spinal cord injury, spinal surgery, cerebral infarction and cerebral hemorrhage; (3) Myocardial infarction, angina, cerebrovascular accident, and heart failure within the past 6 months; (4) Combined with hematologic diseases, gastrointestinal bleeding, diabetic peripheral neuropathy; (5) Recovering from cancer in the past 1 year, or having undergone radiotherapy in the pelvic region, or previous pelvic or lower abdominal surgery or trauma history; (6) Those with neuropsychiatric disorders and those who are unable or unwilling to cooperate; (7) Taking drugs affecting bladder function such as solifenacin, tolterodine, and pyridostigmine bromide in the past 3 months; (8) Urodynamic examination showed neurogenic bladder, unstable contraction of detrusor during the storage period, dyscoordination of detrusor sphincter, and weakness of detrusor contraction, which clearly affected the effect of surgery; (9) Patients with urethral stenosis, prostate cancer, indwelling urethral catheter, and venous thrombosis on venous ultrasound of lower limbs.

Design outcomes

Primary

MeasureTime frame
Number of days to recovery from urinary continence;

Secondary

MeasureTime frame
International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form;

Countries

China

Contacts

Public ContactTie Zhou; AnRen Zhang

Shanghai Fourth People's Hospital, Affiliated to Tongji University

wenzhoutie@163.com+86 139 1836 0532

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026